Brief: Targovax To Collaborate With Oslo University Hospital On TG01 Test IN PHASE 1/2 TRIAL

Circio Holding ASA

10/05/2022 07:28

May 10 (Reuters) - Targovax ASA  TRVX.OL :
    * TARGOVAX AND OSLO UNIVERSITY HOSPITAL ANNOUNCE
COLLABORATION TO
TEST TG
    * TARGOVAX HAS ENTERED INTO AN AGREEMENT WITH OSLO
UNIVERSITY
HOSPITAL (OUS) TO TEST TG01 IN A PHASE 1/2 TRIAL IN 20 PATIENTS
WITH RAS MUTANT MULTIPLE MYELOMA
    * TARGOVAX WILL PROVIDE TG01 DRUG SUPPLY, SCIENTIFIC SUPPORT
AND
FINANCIAL CONTRIBUTION

Source text for Eikon:  ID:nObib4ygZa 
Further company coverage:  TRVX.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))